MedTrace Logo

VIVO Clinical Study

NCT01970007 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 243

Last updated 2021-04-08

Study results available
· View outcomes & findings →

Summary

The purpose of the VIVO Clinical Study is to evaluate the safety and effectiveness of the Zilver® Vena™ Venous Stent in the treatment of symptomatic iliofemoral venous outflow obstruction.

Conditions

  • Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein

Interventions

DEVICE

Zilver Vena Venous Self-Expanding Stent

stenting

Sponsors & Collaborators

  • Cook Research Incorporated

    lead INDUSTRY

Principal Investigators

  • Anthony J. Comerota, MD, FACS, FACC · Inova Vascular

  • Lawrence "Rusty" Hofmann, MD · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-13
Primary Completion
2017-11-20
Completion
2019-11-20

Countries

  • United States
  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01970007 on ClinicalTrials.gov